In addition, with regard to the clinical prognosis, the results indicated that the group associated with low NKILA expression level had a heightened risk of advanced clinical stage, poor histological grades, positive lymph node metastasis, and extended tumor invasion depth. This evidence concerns the gene NKILA and neoplasm.